Determining Virtual Cell Impact for Drug Discovery - with Kristóf Szalay and Gerold Csendes of Turbine

AI in Business by Daniel Faggella

Virtual cell models promise faster, cheaper early-stage drug discovery. However, the industry still lacks a shared way to judge which of these models can actually be trusted on a given problem. In this episode, Kristóf S...View more